Foghorn Therapeutics Inc. SEC filings FHTX
Foghorn Therapeutics Inc. has 354 filings in SEC EDGAR's recent list, going back to Aug 28, 2020. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (exit or restructuring costs, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jan 31, 2025 | — |
| CORRESP | Letter to the SEC | Jan 29, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 29, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 17, 2022 | — |
| CORRESP | Letter to the SEC | Jul 28, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 14, 2022 | — |
| EFFECT | Filing | Apr 19, 2022 | — |
| EFFECT | Filing | Mar 14, 2022 | — |
| CORRESP | Letter to the SEC | Mar 10, 2022 | — |
| UPLOAD | Letter from the SEC | Feb 18, 2022 | — |
| SEC STAFF LETTER | Filing | Oct 29, 2020 | — |
| EFFECT | Filing | Oct 22, 2020 | — |
| CERT | Filing | Oct 22, 2020 | — |
| UPLOAD | Letter from the SEC | Oct 21, 2020 | — |
| SEC STAFF LETTER | Filing | Oct 20, 2020 | — |
| CORRESP | Letter to the SEC | Oct 20, 2020 | — |
| CORRESP | Letter to the SEC | Oct 20, 2020 | — |
| 8-A12B | Filing | Oct 19, 2020 | — |
| CORRESP | Letter to the SEC | Oct 13, 2020 | — |
| CORRESP | Letter to the SEC | Oct 9, 2020 | — |
| UPLOAD | Letter from the SEC | Oct 8, 2020 | — |
| CORRESP | Letter to the SEC | Oct 2, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 24, 2020 | — |
| DRS | Filing | Aug 28, 2020 | — |
Showing 24 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- FHTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1822462
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.